DEC 18, 2019 8:47 AM PST

Stroke Drug Enhances Stem Cell Therapies for Spinal Cord Injuries

WRITTEN BY: Nouran Amin

Using rat models of spinal cord injuries, Yasuhiro Shiga, MD, PhD, thought treating them with stem cell therapy would point to nowhere but the nature of research is patience. At the end, results brought some light on understating pain levels in these kinds of injuries.

"Well, it doesn't seem to be working. I don't see any real change in pain behavior in any of the groups," said Shiga, a visiting scholar at University of California San Diego School of Medicine, apologetically, as he walked into the office of his supervisor, Wendy Campana, PhD, professor in the Department of Anesthesiology and Program in Neuroscience. "Although ... some rats are actually really moving."

What is different that time is researchers added a particular ‘stroke drug’ to the stem cell recipe before injecting into the rats spinal cord. The drug consists of a modified form of tissue-type plasminogen activator (tPA) used to target blood clots in non-hemorrhagic stroke and allows the blood and adequate oxygen to run freely into the brain post-stroke. In addition, TPA is a naturally occurring enzyme known to boost neuronal cell growth and lessen inflammation.

Findings were published in Scientific Reports and describes how researchers treated neuronal precursor cells referred to as progenitors with altered tPA.

"It was striking to see at two and four months the tremendous improvements in the ability of those progenitor cells to survive in the injury cavity," added Campana. "Just keeping these cells alive has been very difficult in past studies."

Learn more about spinal cord injuries:

"The addition of tPA-treated neural precursors didn't reduce pain in this model," Campana said. "But we also didn't exacerbate it -- and to not see increased pain is important safety information for clinical translation to improve motor outcomes. We also don't want worsen the pain burden of patients living with spinal cord injuries."

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 24, 2019
Drug Discovery & Development
NOV 24, 2019
The Fight Against Lethal Childhood Brain Cancers
Scientists used studies on cell and animal models to reveal insights into lethal childhood brain cancers and find promising drug therapeutics. The deadly c...
NOV 27, 2019
Drug Discovery & Development
NOV 27, 2019
Vaccine Causes More Polio Cases than Wild Virus
The World Health Organization (WHO) has confirmed that 11 new cases of polio in five African countries including Nigeria, Congo and Angola were caused by a...
DEC 06, 2019
Health & Medicine
DEC 06, 2019
Federal Restrictions Make It Hard For Cannabis Researchers
With marijuana use becoming more popular in aiding health, scientists race to find clarity around its health benefits and risks. Since the legalization of...
JAN 15, 2020
Cancer
JAN 15, 2020
Hope for patients with AML
Research published recently in the medical journal EMBO Molecular Medicine brings hope for leukemia patients with a report that a common and cheap drug may...
JAN 17, 2020
Cancer
JAN 17, 2020
Could salt nanoparticles kill cancer?
Could salt be the key to killing cancer cells? A new study published in Advanced Materials reports success in using sodium chloride to destroy cancer cells...
FEB 10, 2020
Cardiology
FEB 10, 2020
Blocking Problem Protein Shows Promise for Preventing Heart Attacks
Over time, atherosclerosis, a disease that causes fatty plaques to build up in the arteries, limits the flow of oxygen-rich blood to vital organs. Often le...
Loading Comments...